A carregar...

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package

There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusion of beva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Anothaisintawee, Thunyarat, Leelahavarong, Pattara, Ratanapakorn, Tanapat, Teerawattananon, Yot
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520463/
https://ncbi.nlm.nih.gov/pubmed/23248574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S37458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!